About this trial
This is an open, observational, prospective, descriptive, single-centre study including 60 patients. The study is designed to investigate if IscAlert sensor system can be used for reliable and continuous tissue carbon dioxide (pCO2)- and temperature monitoring in muscular tissue in lower extremity in patients at risk of developing acute compartment syndrome.
Eligibility criteria
Qualifiers
Must have a leg fracture that, perceived by the clinician, could give rise to later developing acute compartment syndrome condition.
Subject must be 18 years or more.
Able to sign informed consent.
Expected cooperation of the patients for the treatment and follow up
Disqualifiers
Another study interfering with current study
Any reason why, in the opinion of the investigator, the patient should not participate.
Patients where a fasciotomy has already been decided should be performed
Trial design
Treatments tested in this trial
- IscAlert sensor(s) in patient with risk of acute compartment syndrome
Treatment groups
Sponsors and collaborators
Oslo University Hospital
Lead sponsor
Sensocure AS
Collaborator